Robert Azelby - 20 Feb 2025 Form 3 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director
Signature
/s/ David Strauss, as Attorney-in-Fact for Robert Azelby
Issuer symbol
TERN
Transactions as of
20 Feb 2025
Transactions value $
$0
Form type
3
Filing time
24 Feb 2025, 18:01:53 UTC
Previous filing
07 Nov 2024
Next filing
05 Jun 2025

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney